Nombre del producto:Cyclopropanamine, 2-(4-fluorophenyl)-, (1R,2S)- (9CI)

IUPAC Name:(1R,2S)-2-(4-fluorophenyl)cyclopropan-1-amine

CAS:220349-80-4
Fórmula molecular:C9H10FN
Pureza:95%+
Número de catálogo:CM433351
Peso molecular:151.18

Unidad de embalaje Stock disponible Precio($) Cantidad
CM433351-1g in stock ƐƐƐȯ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :220349-80-4
Fórmula molecular:C9H10FN
Punto de fusión:-
Código de sonrisas:N[C@@H]1C[C@H]1C1=CC=C(F)C=C1
Densidad:
Número de catálogo:CM433351
Peso molecular:151.18
Punto de ebullición:
Nº Mdl:MFCD17010161
Almacenamiento:

Column Infos

Bomedemstat
Merck recently announces the initiation of the pivotal Phase 3 randomized MK-3543-006 clinical trial of Bomedemstat for Essential Thrombocythemia (ET). Lysine-specific demethylase 1 (LSD1) is critical for the regulation of hematopoietic stem and progenitor cells. Bomedemstat is an investigational small molecule irreversible inhibitor of LSD1 by suppressing progenitor cells during blood cell maturation. It is generally well tolerated in ET patients and demonstrates significant clinical activity as a monotherapy.
Bomedemstat has been granted Orphan Drug and Fast Track Designation for the treatment of ET and myelofibrosis (MF) by the U.S. FDA.